100000 - Document - Document and Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
100010 - Statement - Consolidated Balance Sheets
link:presentationLink
link:calculationLink
link:definitionLink
100020 - Statement - Consolidated Balance Sheets (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
100030 - Statement - Consolidated Statements of Operations
link:presentationLink
link:calculationLink
link:definitionLink
100040 - Statement - Consolidated Statements of Comprehensive Loss
link:presentationLink
link:calculationLink
link:definitionLink
100050 - Statement - Consolidated Statements of Changes in Stockholders' Equity
link:presentationLink
link:calculationLink
link:definitionLink
100060 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
100070 - Statement - Consolidated Statements of Cash Flows
link:presentationLink
link:calculationLink
link:definitionLink
995457 - Disclosure - Cybersecurity Risk Management, Strategy, and Governance
link:presentationLink
link:calculationLink
link:definitionLink
995467 - Disclosure - Nature of Business and Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995477 - Disclosure - Related Party Transactions
link:presentationLink
link:calculationLink
link:definitionLink
995487 - Disclosure - Accrued Expenses
link:presentationLink
link:calculationLink
link:definitionLink
995497 - Disclosure - Paycheck Protection Program
link:presentationLink
link:calculationLink
link:definitionLink
995507 - Disclosure - Convertible Notes Payable
link:presentationLink
link:calculationLink
link:definitionLink
995517 - Disclosure - Simple Agreement For Future Equity
link:presentationLink
link:calculationLink
link:definitionLink
995527 - Disclosure - Fair Value of Financial Liabilities
link:presentationLink
link:calculationLink
link:definitionLink
995537 - Disclosure - Stockholders' Equity
link:presentationLink
link:calculationLink
link:definitionLink
995547 - Disclosure - Employee Retirement Plan
link:presentationLink
link:calculationLink
link:definitionLink
995557 - Disclosure - Commitments and Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
995567 - Disclosure - Income Taxes
link:presentationLink
link:calculationLink
link:definitionLink
995577 - Disclosure - Segment Information
link:presentationLink
link:calculationLink
link:definitionLink
995587 - Disclosure - Subsequent Events
link:presentationLink
link:calculationLink
link:definitionLink
995597 - Disclosure - Nature of Business and Summary of Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995607 - Disclosure - Nature of Business and Summary of Significant Accounting Policies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995617 - Disclosure - Accrued Expenses (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995627 - Disclosure - Fair Value of Financial Liabilities (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995637 - Disclosure - Stockholders' Equity (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995647 - Disclosure - Income Taxes (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995657 - Disclosure - Nature of Business and Summary of Significant Accounting Policies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995667 - Disclosure - Nature of Business and Summary of Significant Accounting Policies - Summary of Antidilutive Shares Excluded from Calculation of Dilutive Loss Per Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995677 - Disclosure - Related Party Transactions - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995687 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995697 - Disclosure - Accrued Expenses - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995707 - Disclosure - Paycheck Protection Program - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995717 - Disclosure - Convertible Notes Payable - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995727 - Disclosure - Simple Agreement For Future Equity - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995737 - Disclosure - Fair Value of Financial Liabilities - Schedule of Fair Value Measurements of Embedded Derivative Liabilities and Warrant Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995747 - Disclosure - Fair Value of Financial Liabilities - Schedule of Changes in Fair Value of the Derivative Liabilities and Warrant Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995757 - Disclosure - Fair Value of Financial Liabilities - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995767 - Disclosure - Stockholders' Equity - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995777 - Disclosure - Stockholders' Equity - Additional Information (Details1)
link:presentationLink
link:calculationLink
link:definitionLink
995787 - Disclosure - Stockholders' Equity - Schedule of Unvested Restricted Shares (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995797 - Disclosure - Stockholders' Equity - Schedule of Warrants Exercised (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995807 - Disclosure - Stockholders' Equity - Assumptions used in Calculating Value of Warrants Granted (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995817 - Disclosure - Stockholders' Equity - Summary of Activity and Information regarding Outstanding and Exercisable Options (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995827 - Disclosure - Stockholders' Equity - Assumptions used in Calculating Value of Options Granted (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995837 - Disclosure - Stockholders' Equity - Summary of Stock Based Compensation Expense (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995847 - Disclosure - Employee Retirement Plan (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995857 - Disclosure - Commitments And Contingencies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995867 - Disclosure - Income Taxes - Summary of Net Deferred Tax Assets (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995877 - Disclosure - Income Taxes - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995887 - Disclosure - Income Taxes - Schedule of Effective Tax Rate of Income Tax Benefit Differs from Federal Statutory Rate (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995897 - Disclosure - Segment Information - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995907 - Disclosure - Subsequent Events - Additional Information - (Details)
link:presentationLink
link:calculationLink
link:definitionLink
Statement [Line Items]
Statement [Line Items]
Certain risks and uncertainties.
Certain Risks And Uncertainties Policy [Text Block]
Certain Risks and Uncertainties
Debt Instrument [Axis]
Cybersecurity Risk Board of Directors Oversight [Text Block]
Plan Name [Domain]
Plan Name
Exercises Of Warrants
Exercises of warrants.
Exercise of warrants
Impact of the COVID-19 pandemic on operations.
Impact of the COVID-19 Pandemic on Operations [Policy Text Block]
Impact of the COVID-19 Pandemic on our Operations
Entity Address Postal Zip Code
Entity Address Postal Zip Code
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]
Warrant description
Warrant Description
Warrant Description
Net sales upto one billion.
Net Sales Upto One Billion [Member]
Net sales up to $1,000,000,000
Conversion price
Common Stock Conversion Price
Common stock conversion price.
Fair Value, Recurring and Nonrecurring [Table]
Entity Incorporation State Country Code
Entity Incorporation State Country Code
State of incorporation
Unrecognized stock compensation expense
Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount
Number of Operating Segments
Number of operating segment
Louie Ngar Yee [Member]
Louie Ngar Yee.
Louie Ngar Yee
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
Weighted Average Exercise Price, Options exercisable
Stock Issued During Period Value Restricted Stock Award Gross
Issuance of restricted stock
Shares Outstanding
Balance, Shares
Balance, Shares
Fair Value Hierarchy and NAV [Axis]
Auditor Name
Level 2
Fair Value, Inputs, Level 2 [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Net operating loss carryforwards, expiration year
Operating Loss Carryforwards Expiration Year
Operating loss carryforwards expiration year.
Simple agreement for future equity issued
Simple Agreement for Future Equity Issued
Simple agreement for future equity issued.
Long-Term Debt, Type [Domain]
Restricted Common Stock Awards
Restricted Common Stock Award [Member]
Restricted common stock award.
Tax Credit Carryforward, Name [Domain]
Amendments of warrants.
Amendments Of Warrants
Amendment of warrants
Regeneron pharmaceuticals inc.
Regeneron Pharmaceuticals Inc [Member]
Regeneron
Commitments And Contingencies Disclosure [Text Block]
Commitments and Contingencies
FGMK Business Holdings, LLC [Member]
FGMK Business Holdings, LLC
FGMK Business Holdings, LLC
Derivatives, Policy [Policy Text Block]
Derivative Financial Instruments
Deferred Compensation Arrangement with Individual, Share-Based Payment [Table]
Class of warrant or right additional purchase aggregate of common stock.
Class of Warrant or Right Additional Purchase Aggregate of Common Stock
Class of warrant or right additional purchase aggregate of common stock
Shares vesting percentage
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage
Arrangements And Nonarrangement Transactions [Member]
Collaborative Arrangement and Arrangement Other than Collaborative
Related Party Transaction [Line Items]
Common stock warrants.
Common Stock Warrants Policy [Text Block]
Common Stock Warrants
Cybersecurity Risk Management Processes Integrated [Text Block]
Concentration Risk Benchmark [Axis]
Stockholders' Equity
Stockholders Equity Note Disclosure [Text Block]
Title and Position [Axis]
University of texas european.
University Of Texas European [Member]
University Of Texas European
Award Date [Axis]
Award Date
Sale Of Stock Name Of Transaction [Domain]
Sale of Stock
Entity Central Index Key
Entity Central Index Key
Sales Agent Commissions
Sales agent commissions.
Commissions paid
Class of warrants exercised.
Class Of Warrants Exercised
Warrants Outstanding, Exercised
MAIA Stock Warrants
Warrants
Shares Issuable upon Exercise of Warrants
January 27 to May 31, 2022
January twenty seven to may thirty one two thousand twenty two.
January Twenty Seven To May Thirty One Two Thousand Twenty Two [Member]
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
Cancelled/forfeited, Options Outstanding
Options Outstanding, Cancelled/forfeited
Share based compensation arrangement by share based payment award fair value assumptions percentage of increase in stock outstanding fully diluted.
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Percentage Of Increase In Stock Outstanding Fully Diluted
Percentage of increase in stock outstanding fully diluted
Tax credits, expiration year
Research And Experimentation Tax Credits Carryforwards Expiration Year
Research and Experimentation Tax Credits Carryforwards Expiration Year
Auditor Opinion
Auditor Opinion [Text Block]
Increase Decrease In Operating Capital [Abstract]
Change in operating assets and liabilities:
Common stock, shares issued
Common Stock Shares Issued
Probability percentage of default, change in control or dissolution
Probability Percentage of Default, Change in Control or Dissolution
Probability percentage of default, change in control or dissolution.
Oustside Investors Warrants
Outside Investors Warrants [Member]
Outside investors warrants
Proceeds from convertible debt
Proceeds From Convertible Debt
Proceeds from issuance of convertible notes, warrants, and embedded conversion features
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
Risk-free interest rate, minimum
Defined Benefit Plan [Abstract]
Increase Decrease In Prepaid Deferred Expense And Other Assets
Prepaid expenses and other current assets
Award Date [Domain]
Award Date
Income Statement [Abstract]
Non-affiliated Investors [Member]
Non-affiliated investors.
Non-Affiliated Investors
Number of founders terminated
Number of Founders Terminated
Number of founders terminated.
Entity Address State Or Province
Entity Address State Or Province
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]
Nature of Business and Summary of Significant Accounting Policies
Pretax book loss
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total
Loss Contingencies [Table]
Loss Contingencies [Table]
Accounting Standards Update [Extensible Enumeration]
Percentage of royalty payments on net sales description.
Percentage Of Royalty Payments On Net Sales Description
Percentage of royalty description
Warrant value
Warrant Value
Warrant value.
Two thousand and twenty one warrants.
2021 warrants
Two Thousand And Twenty One Warrants [Member]
Investor warrants.
Investor Warrants [Member]
Investor Warrants
Warrant liability
Warrant Liability Noncurrent
Warrant liability noncurrent.
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
Aggregate Intrinsic Value, Options exercisable
Cover [Abstract]
Subsequent Event [Line Items]
Earnings Per Share Basic
Net loss per share basic
Earnings Per Share, Basic, Total
Debt discount and value of embedded put feature
DebtDiscountAndValueOfEmbeddedPutFeature
Debt Discount And Value Of Embedded Put Feature
Deferred tax asset, increase in valuation allowance
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Warrant issued as liability.
Warrant Issued As Liability
Warrant issued
Amendment Of Warrant Agreements [Member]
Amendment of warrant agreements.
Amendment Of Warrant Agreements
Operating Expenses [Abstract]
Operating expenses:
Document Annual Report
MAIA Drug Development Corporation.
M A I A Drug Development Corporation [Member]
MAIA DD
MAIA Drug Development Corporation
Stock-based compensation expense related to accrued bonus balance
Stock compensation expense
Stock-based compensation
Stock Issued During Period Value Warrants
Stock issued during period value warrants.
Issuance of warrants in connection
Cashless exercise at fair market value per share.
Cashless Exercise At Fair Market Value Per Share
Cashless exercise at fair market value per share
Nonvested Restricted Stock Shares Activity Table [Text Block]
Schedule of Unvested Restricted Shares
Retained Earnings Accumulated Deficit
Accumulated deficit
Retained Earnings (Accumulated Deficit), Total
Accumulated deficit
Plan Name [Axis]
Plan Name
Australian
Australian Taxation Office [Member]
Off Balance Sheet Credit Exposure Policy Policy [Text Block]
Off-Balance Sheet Risk and Concentrations of Credit Risk
Schedule of Changes in Fair Value of the Derivative Liabilities and Warrant Liabilities
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Segment Reporting [Abstract]
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
Options Outstanding, Ending balance
Options Outstanding, Beginning balance
Stock options outstanding
Assets Current [Abstract]
Current assets:
Common Stock Capital Shares Reserved For Future Issuance
Common stock reserved for issuance
Patent and technology license agreement.
Patent And Technology License Agreement [Member]
Patent and Technology License Agreement
Defined Benefit Plan [Table]
Net Cash Provided By Used In Operating Activities
Net cash used in operating activities
Accumulated other comprehensive loss
Accumulated Other Comprehensive Income Loss Net Of Tax
Accumulated Other Comprehensive Income (Loss), Net of Tax, Total
Debt instrument term
Debt Instrument, Term
Net operating loss carryforwards
Operating Loss Carryforwards
Payment of Offering transactions costs.
Payment Of Offering Transactions Costs
Payment of offering transactions costs
Net Cash Provided By Used In Operating Activities [Abstract]
Cash flows from operating activities:
Recurring
Fair Value, Recurring [Member]
Other Income And Expenses [Abstract]
Other income (expense):
Common Stock Par Or Stated Value Per Share
Common stock, par value
Common stock, par value
Shares Issuable upon Exercise of Stock Options
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
Percentage of voting power defining change of control
Percentage Of Voting Power Defining Change Of Control
Percentage Of Voting Power Defining Change Of Control
Statement Of Cash Flows [Abstract]
Counterparty Name [Axis]
Antidilutive Securities Name [Domain]
Antidilutive Securities, Name
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Warrants to purchase aggregate of common stock
Other
Deferred Tax Assets, Other
Extinguishment of outstanding principal and interest written off amount
Extinguishment of Outstanding Principal and Interest Written Off Amount
Extinguishment of outstanding principal and interest written off amount.
Restricted Stock [Member]
Restricted Stock Awards
Statement Equity Components [Axis]
Equity Components
Entity Address Address Line1
Entity Address Address Line1
Gain on extinguishment of debt
Extinguishment of derivative liability in connection with debt conversion
Extinguishment of derivative liability in connection with debt conversion
Extinguishment of Debt, Amount
Related Party Transaction [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Shares granted
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]
Deemed dividend declared.
Deemed Dividend Declared
Deemed dividend declared
Valuation Approach and Technique [Axis]
Proceeds from sale of common stock in follow-on offering
Proceeds from sale of common stock in follow-on offering.
Proceeds From Sale Of Common Stock In Follow-on Offering
Deferred tax assets:
Deferred Tax Assets, Net of Valuation Allowance [Abstract]
Subsequent Event Type [Axis]
Warrants issued in connection with the at-the-market offering.
Warrants Issued In Connection With The At-The-Market Offering
Warrants issued in connection with the At-The-Market offering
Net sales upto one million.
Net Sales Upto One Million [Member]
Net sales up to $1,000,000
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]
Summary of Antidilutive Shares Excluded from Calculation of Dilutive Loss Per Share
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Risk free interest rate
Private Placement Offering [Member]
Private placement offering.
Private Placement Offering
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
Shares, Unvested balance
Shares, Unvested balance
Unvested shares
Entity Voluntary Filers
Subsidiary Or Equity Method Investee [Line Items]
Subsidiary or Equity Method Investee [Line Items]
Amendment Flag
Amendment Flag
Operating Loss Carryforwards [Table]
Percentage of probability of the convertible notes maturity
Percentage Of Probability Of The Convertible Notes Maturity
Percentage of probability of the convertible notes maturity.
Warrant fee paid in cash.
Warrant Fee Paid in Cash
Warrant fee paid in cash
Employee salary deferrals
Defined Contribution Plan Employer Salary
Defined contribution plan employer alary.
Federal
Domestic Tax Jurisdiction [Member]
Debt Instrument, Name [Domain]
Derivative liability on convertible notes payable
Debt discount and derivative liability at the issuance date
Embedded Derivative, Fair Value of Embedded Derivative Liability
Derivative liability on convertible notes payable
Derivative Liability on Convertible Notes Payable
Derivative liability on convertible notes payable.
Stock price per share
Common stock per share
Sale of common stock, price per share
Net sales above one billion.
Net Sales Above One Billion [Member]
Net sales above $1,000,000,000
Stock Issued During Period Shares Stock Options Exercised
Issuance of common shares upon exercise of stock options, Shares
Issuance of common shares upon exercise of stock options, Shares
Options Outstanding, Exercised
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
Options Outstanding, Options exercisable
Research And Development Expense [Member]
Research and Development [Member]
Assumptions used in Calculating Value of Warrants Granted
Schedule of Share-Based Payment Award, Warrants, Valuation Assumptions [Table Text Block]
Schedule of share-based payment award, warrants, valuation assumptions.
Equity Component [Domain]
Equity Component
Range [Member]
Statistical Measurement
Document Financial Statement Error Correction [Flag]
Document Financial Statement Error Correction
General And Administrative Expense
General and administrative expenses
General and Administrative Expense, Total
Unvested restricted stock awards.
Unvested Restricted Stock Awards [Member]
Unvested Restricted Stock Awards
Short-Term Debt [Line Items]
Class of warrants weighted average exercise price, exercised.
Class Of Warrants Weighted Average Exercise Price Exercised
Weighted Average Exercise Price, Exercised
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]
Founder.
Founder [Member]
Founder
Cybersecurity Risk Management Processes Integrated [Flag]
Profit Loss
Net loss
Net loss
Net loss
Warrants issued
Class of warrants issued.
Class Of Warrants Issued
Warrants Outstanding, Issued
Preferred Stock Shares Issued
Preferred stock, shares issued
Proceeds From Stock Options Exercised
Proceeds from exercise of stock options
Debt Instrument, Unamortized Discount
Debt discount
Debt Instrument, Unamortized Discount, Total
Schedule of derivative liabilities related to convertible notes
Schedule of Derivative Liabilities at Fair Value [Table Text Block]
Payables And Accruals [Abstract]
Loss on fair value of warrants over proceeds
Gain (Loss) Fair Value of Warrants Over Proceeds
Gain (loss) fair value of warrants over proceeds.
Loss on fair value of warrants over proceeds
Share Based Compensation Arrangement By Share Based Payment Award Options, Share Authorized Percentage
Share based compensation arrangement by share based payment award options share authorized percentage.
Shares authorized percentage
2021 Promissory Note
Two Thousand And Twenty One Convertible Promissory Note [Member]
Two thousand and twenty one convertible promissory note.
Prepaid Expense and Other Assets, Current
Prepaid expenses and other current assets
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
Risk-free interest rate, maximum
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
Weighted Average Exercise Price, Cancelled/forfeited
Type Of Arrangement [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative
Research program expenditures.
Research Program Expenditures
Research program expenditures
Comprehensive loss
Comprehensive Income Net Of Tax
Common Stock Shares Outstanding
Common Stock, Shares, Outstanding, Ending Balance
Common Stock, Shares, Outstanding, Beginning Balance
Common stock, shares outstanding
Fair Value Measurement Policy Policy [Text Block]
Fair Value Measurements
Share based compensation arrangement by share based payment award fair value assumptions percentage of shares granted.
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Percentage Of Shares Granted
Percentage of shares granted
Class of warrant or right date from which warrants or rights expire.
Class of Warrant or Right Date from which Warrants or Rights Expire
Class of warrant or right date from which warrants or rights expire
Preferred Stock Par Or Stated Value Per Share
Preferred stock, par value
Research and development
Deferred Tax Asset, In-Process Research and Development
H.C. Wainwright and Co LLC.
H C Wainwright and Co L L C [Member]
H.C. Wainwright and Co., LLC
Minority Interest Ownership Percentage By Parent
Ownership percentage by parent
P P P Loan Program
PPP Loan Program [Member]
PPP loan program.
Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]
Antidilutive Securities
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
Proceeds from equity financing
Proceeds from Issuance or Sale of Equity
Proceeds from Issuance or Sale of Equity, Total
Defined Benefit Plan Disclosure [Line Items]
Cash
Cash
University Of Texas Southwestern [Member]
UTSW
University of texas southwestern.
Direct offering.
Direct Offering [Member]
Direct Offering
Entity Interactive Data Current
Entity Interactive Data Current
Stan Smith.
Stan Smith [Member]
Stan Smith
January 1 to January 26, 2022
January one to january twenty six two thousand twenty two.
January One To January Twenty Six Two Thousand Twenty Two [Member]
Milestone payment.
Milestone Payment
Milestone payment
Combined milestone payments maximum.
Combined Milestone Payments Maximum
Combined milestone payment maximum
Retirement Plan Type [Axis]
Payments due related to milestones.
Payments Due Related To Milestones
Payments due related to milestones
Accounting Standards Update [Domain]
Consolidated Entities [Axis]
Current cash reserves
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
Cash at end of period
Cash at beginning of period
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Total
Related Party Transactions
Related Party Transactions Disclosure [Text Block]
Range [Axis]
Statistical Measurement
Research Tax Credit Carryforward [Member]
Research and Development
Related and Nonrelated Parties [Domain]
Related Party
Restricted Stock or Unit Expense
Stock compensation expense
Parent Company [Member]
MAIA Biotechnology, Inc.
Cash paid for services provided
Cash Paid for Services Provided
Cash paid for services provided.
Director
Director [Member]
Warrants Issued In Connection With Private Placement Offering3
Warranis Issued in connection with private placement offering3
Warrants issued with private placement 3 offering
Convertible promissory notes to related parties
Convertible Promissory Notes To Related Parties
Convertible promissory notes to related parties.
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
Unrecognized compensation expense, recognized period
Proceeds from Issuance of Private Placement
Aggregate purchase price
Research And Development Expense Policy
Research and Development
Ownership [Domain]
Statement of Income Location, Balance [Axis]
Income Statement Location
Short-Term Debt [Table]
Number of founders to whom shares granted
Number of Founders to Whom Shares Granted
Number of founders to whom shares granted.
Class of warrants expired.
Class of Warrants Expired
Warrants Outstanding, Expired
Assets
Total assets
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
Fair value assumptions, contractual term
Expected term (in years)
At the market offering agreement.
At The Market Offering Agreement [Member]
At The Market Offering Agreement
Payroll expense related to accrued bonus balance.
Payroll Expense Related To Accrued Bonus Balance
Payroll expense related to accrued bonus balance
Foreign loss
Income (Loss) from Continuing Operations before Income Taxes, Foreign
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
Founders shares vested
Shares, Vested
New Accounting Pronouncements Policy Policy [Text Block]
Recent Accounting Standards
Entity Address City Or Town
Entity Address City Or Town
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income [Member]
Equity [Abstract]
Auditor Location
Payments of Stock Issuance Costs
Cash issuance cost, net
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]
Stock Issued During Period Value Warrants to Underwiter
Stock Issued During Period Value Warrants to Underwiter
Issuance of warrants to underwriter in connection with initial public offering
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
Founders shares cancelled
Convertible promissory notes to settle loan
Convertible Promissory Notes To Settle Loan
Convertible promissory notes to settle loan.
Warrant modification, value.
Warrant Modification Value
Warrant modification, value
Accrued bonus
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Bonuses
Convertible note amount
Principal amount
Debt Instrument, Face Amount
Employee Retirement Plan
Defined Benefit Plan [Text Block]
Deferred compensation
Liability, Defined Benefit Plan, Current
Deferred compensation to former officers
Loss (Gain) on fair value of embedded features
Loss (Gain) on fair value of embedded features
Change in fair value of embedded features.
Change In Fair Value Of Embedded Features
Change in fair value of embedded features
Change in fair value of embedded features
Deferred Charges Policy [Text Block]
Deferred Offering Costs
Accrued severance
Accrued severance, current.
Accrued Severance, Current
Accrued severance
Class of warrant or right, number of securities, vested
Class of Warrant or Right, Number of Securities, Vested
Warrant shares vested
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]
Liquidity.
Liquidity [Policy Text Block]
Liquidity
Principal amount forgiven
Debt Instrument, Decrease, Forgiveness
Private Placement
Private Placement [Member]
Stock-based compensation
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent
Percentage of the conversion price
Convertible Debt Conversion Price Percentage Of The Equity Financing
Convertible Debt Conversion Price Percentage Of The Equity Financing
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]
Class of warrants exercised
Warrants Exercised
Share-based compensation arrangement by share-based payment award, options, exercises in period.
Fair Value Disclosures [Abstract]
Private Placement Offering Four [Member]
Private placement offering four
Private Placement Round 4
Proceeds from at the market offering.
Proceeds From At The Market Offering
Proceeds from At-The-Market offering
Warrants exercised, shares.
Warrants Exercised Shares
Warrants exercised, shares
Entity Public Float
Sylvia Guerrero
Sylvia Guerrero [Member]
Sylvia guerrero.
Issuance of common shares, value
Stock Issued During Period, Value, New Issues
Issuance of common shares
Number of shares vesting quarterly instalments
Share-Based Compensation Arrangement by Share-Based Payment Award, Vesting Quarterly Instalments, Number
Share-based compensation arrangement by share-based payment award, vesting quarterly instalments, number
Net deferred tax asset
Deferred Tax Assets, Net of Valuation Allowance
Stock Issued During Period Value Stock Options Exercised
Issuance of common shares upon exercise of stock options
Liabilities Current [Abstract]
Current liabilities:
Class of warrants weighted average exercise price expired.
Class Of Warrants Weighted Average Exercise Price Expired
Weighted Average Exercise Price, Expired
Document Type
Document Type
Accounting Standards Update [Axis]
Net operating loss carryforward limited percentage of taxable income
Operating Loss Carryforward Limited Percentage of Taxable Income
Operating loss carryforward limited percentage of taxable income.
Issuance of stock options to satisfy accrued bonus.
Issuance Of Stock Options To Satisfy Accrued Bonus
Issuance of stock options to satisfy accrued bonus
Security12b Title
Security12b Title
Cash and Cash Equivalents, at Carrying Value
Cash equivalents
Cash and Cash Equivalents, at Carrying Value, Total
2019 Promissory Note
Two Thousand And Nineteen Promissory Note [Member]
Two Thousand And Nineteen Promissory Note [Member]
Fair value of stock options issued to settle accrued bonus balance
Fair Value of Stock Options Issued to Settle Accrued Bonus Balance
Fair value of stock options issued to settle accrued bonus balance.
Statement Of Stockholders Equity [Abstract]
Document Fiscal Period Focus
Document Fiscal Period Focus
Research And Development Expense
Research and development expenses
Research and Development Expense, Total
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
Options outstanding, Granted
Available shares
Options issued for accrued bonus.
Options Issued For Accrued Bonus
Options issued for accrued bonus
Warrant outstanding and exercisable
Class of Warrant or Right Outstanding and Exercisable
Class of warrant or right outstanding and exercisable.
Black sholes method.
Black Sholes Method [Member]
Black-Sholes Method
Cash, FDIC Insured Amount
Cash deposits federally insured limits
Warrants issued to underwriters in connection with the initial public offering
Warrants issued to underwriters in connection with the initial public offering
Subsequent Event Type [Domain]
Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]
Assumptions used in Calculating Value of Options Granted
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
Foreign currency translation adjustment
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent, Total
Foreign currency translation adjustment
401 (K)
The401 K Plan Member
The401 K Plan.
Babyshelf Offering.
Babyshelf Offering [Member]
Babyshelf Offering
Issuance of warrants.
Issuance Of Warrants
Issuance of Warrants
Class of Warrant or Right, Exercise Price of Warrants or Rights
Warrants exercise price, per share
Proceeds from unsecured loan
Proceeds from Issuance of Unsecured Debt
Subsidiary Sale Of Stock [Axis]
Sale of Stock
Class of Warrant or Right, Date from which Warrants or Rights Exercisable
Warrants and rights exercisable period
Statement Of Income And Comprehensive Income [Abstract]
Income Tax Disclosure [Text Block]
Income Taxes
Schedule of Effective Tax Rate of Income Tax Benefit Differs from Federal Statutory Rate
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
Cybersecurity Risk Management, Strategy, and Governance [Abstract]
Ownership [Axis]
Consolidated Entities [Domain]
Warrant liabilities:
Warrants and Rights Note Disclosure [Abstract]
Warrants issued in connection with the direct offering.
Warrants Issued In Connection With The Direct Offering
Warrants issued in connection with the direct offering
Line of Credit Facility [Line Items]
Accounting Standards Update 2023-07 [Member]
ASU 2023-07
Share-based compensation arrangement by share-based payment award, fair value assumptions, exercise price percentage.
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price Percentage
Exercise price percentage
Other Accrued Liabilities Current
Other
Increase Decrease In Accounts Payable
Accounts payable
Increase (Decrease) in Accounts Payable, Total
Schedule Of Subsidiary Or Equity Method Investee [Table]
Schedule Of Subsidiary Or Equity Method Investee [Table]
Entity Address Address Line2
Entity Address, Address Line Two
Liabilities And Stockholders Equity [Abstract]
LIABILITIES AND STOCKHOLDERS' EQUITY
Document Period End Date
Document Period End Date
Net Cash Provided By Used In Financing Activities
Net cash provided by financing activities
Other nondeductible expenses/(nontaxable income)
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent
ICFR Auditor Attestation Flag
Income tax benefit
Effective Income Tax Rate Reconciliation, Percent
Long term liabilities:
Liabilities, Noncurrent [Abstract]
Stock Issued During Period Shares Restricted Stock Award Gross
Issuance of restricted stock, Shares
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
Antidilutive securities excluded from computation of earnings per share, amount
Stock-based compensation expense
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total
Stock-based compensation expense - MAIA
Accrued Liabilities Current
Accrued expenses
Total accrued expenses
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description
Income tax provision
Income Tax Expense (Benefit)
Income Tax Expense (Benefit), Total
Stock Issued During Period, Share, Warrants Exercised
Stock issued during period, share, warrants exercised.
Exercise of warrants, shares
Trading Symbol
Trading Symbol
Debt conversion, original debt, amount
Debt Conversion, Original Debt, Amount
Registered Direct Offering [Member]
Registered Direct Offering
Registered direct offering.
Probability percentage of equity financing
Probability Percentage of Equity Financing
Probability percentage of equity financing.
Remaining Warrants And Rights Outstanding
Remaining warrants and rights outstanding.
Remaining warrant liability
Total net deferred tax assets before valuation allowance
Deferred Tax Assets, Gross
Two thousand twenty one equity incentive plan.
Two Thousand Twenty One Equity Incentive Plan [Member]
2021 Equity Incentive Plan
Warrants to purchase shares of common stock
Class Of Warrant Or Right Outstanding
Warrants Outstanding, Ending balance
Warrants Outstanding, Beginning balance
Conversion price
Conversion price (in dollars per share)
Debt Instrument, Convertible, Conversion Price
Exercise of warrants
Stock Issued During Period, Value, Warrants Exercised
Stock issued during period, value, warrants exercised.
Related Party Transactions [Abstract]
Change in Accounting Principle, Accounting Standards Update, Adopted [true false]
Selling General And Administrative Expenses Policy [Text Block]
General and Administrative
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]
Summary of Stock Based Compensation Expense
Capital shares, authorized
Capital Units, Authorized
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
Unrecognized compensation
Deferred Costs, Noncurrent
Deferred offering costs
Deferred Costs, Noncurrent, Total
Use Of Estimates
Use of Estimates
Other Operating Income Expense Net
Other income (expense), net
Convertible notes outstanding
Convertible Notes Outstanding
Convertible notes outstanding.
Australian research and development incentives.
Australian Research And Development Incentives
Australian research and development incentives
Cash And Cash Equivalents Policy [Text Block]
Cash and Cash Equivalents
Research and development incentive.
Research And Development Incentive Policy [Text Block]
Research And Development Incentive
Convertible note issued
Issuance of common shares upon conversion of convertible notes, value
Issuance of common shares upon conversion of convertible notes
Related Party [Member]
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
Expected volatility, minimum
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
Expected dividend yield
Security Exchange Name
Security Exchange Name
Counterparty Name [Domain]
Operating Loss Carryforwards [Line Items]
Total operating expenses
Operating Expenses
Warrants Issued In Connection With Private Placement Offering 2
Warrants issued in connection with private placement offering 2.
Warrants issued with private placement 2 offering
Fair Value of Financial Liabilities
Fair Value Disclosures [Text Block]
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
Weighted-average grant date fair value
Weighted-average fair value
Subsidiary, Ownership Percentage, Noncontrolling Owner
Minority stockholder ownership percentage
Subsequent Event [Member]
Subsequent Event
Maximum [Member]
Maximum
Liabilities And Stockholders Equity
Total liabilities and stockholders' equity
June 1, 2022 to August 1, 2022
June one two thousand twenty two to august one two thousand twenty two.
June One Two Thousand Twenty Two to August One Two Thousand Twenty Two [Member]
Class of warrants weighted average remaining contractual term.
Class Of Warrants Weighted Average Remaining Contractual Term
Weighted Average Remaining Contractual Term in Years
Gain (loss) on extinguishment of debt
Gain on extinguishment of debt
Loss on extinguishment of convertible notes and convertible notes, related parties
Gain (Loss) on Extinguishment of Debt, Total
Loss on extinguishment of convertible notes
Supplemental Cash Flow Information [Abstract]
Supplemental disclosure of cash flow information:
Converted common stock under SAFE agreement
Number Of Common Shares Converted Under S A F E Agreement
Number of common shares converted under S A F E agreement.
Earnings Per Share Diluted
Net loss per share diluted
Earnings Per Share, Diluted, Total
Entity Ex Transition Period
Entity Ex Transition Period
Total liabilities
Liabilities
Issuance of common shares upon exercise of warrants shares.
Issuance Of Common Shares Upon Exercise Of Warrants Shares
Issuance of common shares upon exercise of warrants, Shares
Fair Value Hierarchy and NAV [Domain]
Assets Current
Total current assets
Simple Agreement For Future Equity
Simple Agreement For Future Equity Disclosure [Text Block]
Simple agreement for future equity
Stock Issued During Period, Shares, New Issues
Issuance of common shares, Shares
Number of common stock Issued and sold
Percentage of issuable upon conversion of exercise price
Percentage of Issuable Upon Conversion of Exercise Price
Percentage of issuable upon conversion of exercise price.
Change in valuation allowance
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent
Shares vesting period
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
Transaction costs.
Transaction Costs
Transaction costs
Steven Chaouki.
Steven Chaouki [Member]
Steven Chaouki
Entity Filer Category
Entity Filer Category
Share converted
Debt Conversion, Converted Instrument, Shares Issued
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right
Warrants to purchase common stock
Balance
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
Balance
Total stockholders' equity
Proceeds from common stock net of issuance costs.
Proceeds From Common Stock Net Of Issuance Costs
Gross proceeds from common stock
Net proceeds from common stock
Reclassification Of Liability Classified Warrants To Equity
Reclassification of liability classified warrants to equity.
Reclassification of liability classified warrants to equity
THIO Therapeutics, Inc.
T H I O Therapeutics Inc [Member]
THIO
THIO Therapeutics, Inc.
Foreign currency translation adjustment.
Foreign Currency Translation Adjustment
Foreign currency translation adjustment
Current Fiscal Year End Date
Current Fiscal Year End Date
FGMK LLC [Member]
Fgmk llc.
FGMK, LLC
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Share Based Compensation
Stock-based compensation
Share-Based Payment Arrangement, Noncash Expense, Total
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
Aggregate Intrinsic Value
Related Party Transactions By Related Party [Axis]
Related Party
Accrued research and development costs current.
Accrued Research And Development Costs Current
Research and development costs
Deferred Compensation Arrangement with Individual, Share-Based Payments [Line Items]
Number of warrants issued.
Number of warrants issued
Number of directors to whom shares granted
Number of Directors to Whom Shares Granted
Number of directors to whom shares granted.
Entity Registrant Name
Entity Registrant Name
Number of warrants exercised
Number Of Warrants Exercised
Number of warrants exercised.
Number of Reportable Segments
Number of reporting segment
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Maturity date
Debt Instrument, Maturity Date
Entity Emerging Growth Company
Entity Emerging Growth Company
Paycheck Protection Program
Paycheck Protection Program [Text Block]
Paycheck protection program.
Accounting Standards Update 2016-13 [Member]
ASU 2016-13
Weighted Average Number Of Shares Outstanding Basic
Weighted average common shares outstanding basic
Weighted Average Number of Shares Outstanding, Basic, Total
Loss Contingencies [Line Items]
Loss Contingencies [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
Expected volatility, maximum
Common Stock Shares Authorized
Common stock, shares authorized
Lessor Leases Policy [Text Block]
Leases
Common shares upon exercise of warrants, Shares
Common Shares Upon Exercise Of Warrants Shares
Common shares upon exercise of warrants shares.
Gross proceeds from sale of common stock
Proceeds from Issuance of Common Stock
Proceeds from sale of common stock
Level 1
Fair Value, Inputs, Level 1 [Member]
Minimum gross proceeds from equity financing required for conversion of debt
Minimum Gross Proceeds From Equity Financing Required For Conversion Of Debt
Minimum Gross Proceeds From Equity Financing Required For Conversion Of Debt
Debt Disclosure [Abstract]
Private Placement Offering Five [Member]
Private placement offering five.
Private Placement Round 5
Documents Incorporated by Reference [Text Block]
Documents Incorporated by Reference
Change in fair value of warrant liability
Change in fair value of warrant liability.
Change In Fair Value Of Warrant Liability
Change in fair value of warrant liability
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
Weighted Average Exercise Price, Granted
Claim expiration term.
Claim Expiration Term
Claim expiration period
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
Weighted Average Remaining Contractual Term in Years
Earnings Per Share Policy [Text Block]
Net Loss Per Share
General and Administrative Expense
General And Administrative Expense [Member]
General and Administrative [Member]
Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]
Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]
Percentage of probability of default change in control or dissolution
Percentage Of Probability Of Default Change In Control Or Dissolution
Percentage of probability of default change In control Or dissolution.
Cybersecurity Risk Role of Management [Text Block]
BeiGene Swizerland GmbH [Member]
BeiGene Swizerland GmbH.
BeiGene
Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]
Summary of Activity and Information regarding Outstanding and Exercisable Options
Alumni Capital LP
Alumni Capital LP.
Alumni Capital LP [Member]
Income Tax Disclosure [Abstract]
Stockholders Equity [Abstract]
Stockholders' equity (deficit)
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
Net effect of foreign currency exchange on cash
Net effect of foreign currency exchange on cash
ThinkEquity LLC
ThinkEquity LLC [Member]
ThinkEquity LLC [Member]
Statement [Table]
Statement [Table]
Segment Information
Segment Reporting, Policy [Policy Text Block]
Ramiro Guerrero.
Ramiro Guerrero [Member]
Ramiro Guerrero
Deemed dividend on warrant modification.
Deemed Dividend On Warrant Modification
Deemed dividend on warrant modification
Deemed dividend on warrant modification
warrants exercisable
Class of Warrant or Right, warrants exercisable
Class of warrant or right, warrants exercisable.
Subsequent Event [Table]
Probability percentage of convertible notes outstanding at maturity
Probability Percentage of Convertible Notes Outstanding at Maturity
Probability percentage of convertible notes outstanding at maturity.
Preferred Stock Shares Authorized
Preferred stock, shares authorized
Extinguishment of derivative liability in connection with debt conversion
Extinguishment of Derivative Liability in Connection with Debt Conversion
Extinguishment of derivative liability in connection with debt conversion.
Gain on remeasurement of warrant liability
Change in fair value of warrant liability
Loss (gain) on remeasurement of warrant liability
Loss (gain) on fair value of warrant liability
Entity File Number
Entity File Number
Segment Information
Segment Reporting Disclosure [Text Block]
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
Net increase (decrease) in cash
Earnings Per Share [Abstract]
Net loss per share
Stock-based compensation
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost
State taxes, net of federal tax benefit
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent
Romanian Income Tax
Romanian Income Tax [Member]
Romanian income tax.
Statement Of Financial Position [Abstract]
Tax Credit Carryforward [Axis]
Interest expense
Interest Expense, Operating and Nonoperating
Interest Expense, Total
Interest expense
I P O [Member]
IPO
Entity Incorporation, Date of Incorporation
Date of incorporation
Operating Income (Loss)
Loss from operations
Accrued bonus expense
Accrued Bonuses, Current
Bonus
Shares Issued, Price Per Share
Sale of common stock, price per share
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Volatility rate
Expected volatility
Derivative Asset, Total
Derivative Asset
Derivative instruments
Ratchet.
Ratchet Member
Ratchet
Entity Shell Company
Entity Shell Company
Line of Credit Facility [Table]
Accrued Professional Fees Current
Professional fees
Entity Tax Identification Number
Entity Tax Identification Number
Assets [Abstract]
ASSETS
Expiration of patent rights period
Expiration of Patent Rights Period
Expiration of patent rights period.
Entity Current Reporting Status
Entity Current Reporting Status
Net loss
Net Income (Loss) Available to Common Stockholders, Basic
Net loss attributable to MAIA Biotechnology, Inc. shareholders
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
Weighted Average Remaining Contractual Term in Years, Options exercisable
Schedule of Fair Value Measurements of Embedded Derivative Liabilities and Warrant Liabilities
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]
Stockholders' Equity Note, Stock Split
Common stock, conversion description
Long-Term Debt, Type [Axis]
Subsequent Events [Abstract]
Document Fiscal Year Focus
Document Fiscal Year Focus
Class of warrants weighted average exercise price issued.
Class Of Warrants Weighted Average Exercise Price Issued
Weighted Average Exercise Price, Issued
Weighted-average fair values of warrants issued
Change in Accounting Principle, Accounting Standards Update, Adoption Date
Preferred Stock Value
Preferred stock, $0.0001 par value, 30,000,000 shares authorized at December 31, 2024 and December 31, 2023, 0 shares issued and outstanding
Proceeds from Issuance Initial Public Offering
Gross proceeds from initial public offering
Proceeds from sale of common stock in intial public offering
Tax Credit Carryforward, Amount
Tax credits carryforwards
City Area Code
City Area Code
Liabilities Current
Current liabilities
Total current liabilities
Warrants Issued In Connection With Private Placement Offering 1
Warrants issued in connection with private placement offering 1.
Warrants issued with private placement 1 offering
Research and development incentives receivable.
Research And Development Incentives Receivable
Australia research and development incentives receivable
Description of business, organization, and principles of consolidation.
Description of Business, Organization, and Principles of Consolidation [Policy Text Block]
Description of Business, Organization, and Principles of Consolidation
Statutory federal income tax rate
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
Proceeds from issuance of common stock upon exercise of warrants.
Proceeds From Issuance Of Common Stock Upon Exercise Of Warrants
Proceeds from issuance of common stock upon exercise of warrants
Loss on extinguishment of debt
Effective Income Tax Rate Reconciliation Loss on Extinguishment of Debt
Effective income tax rate reconciliation loss on extinguishment of debt.
Converted shares of common stock
Stock Issued During Period, Shares, Conversion of Convertible Securities
Issuance of common shares upon conversion of convertible notes, Shares
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Local Phone Number
Local Phone Number
Preferred Stock Shares Outstanding
Preferred Stock, Shares Outstanding, Ending Balance
Preferred Stock, Shares Outstanding, Beginning Balance
Preferred stock, shares outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Additional Paid In Capital
Additional paid-in capital
Additional Paid in Capital, Total
Contribution to employee
Defined Contribution Plan, Employer Matching Contribution, Percent of Match
Warrants Issued In Connection With Private Placement Offering 5
Warrants issued in connection with private placement offering 5.
Warrants issued with private placement 5 offering
Income Tax Jurisdiction [Axis]
Retirement Plan Type [Domain]
Income Tax Policy [Text Block]
Income Taxes
Warrants issued with private placement 4 offering
Warrants Issued In Connection With Private Placement Offering 4
Warrants issued in connection with private placement offering 4.
Commitments And Contingencies Disclosure [Abstract]
Summary of Net Deferred Tax Assets
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
Issuance of common shares upon cashless exercise of warrants shares.
Issuance Of Common Shares Upon Cashless Exercise Of Warrants Shares
Issuance of common shares upon cashless exercise of warrants, shares
Amended patent and technology license agreement.
Amended Patent and Technology License Agreement [Member]
Amended Patent and Technology License Agreement
Income Tax Jurisdiction [Domain]
Percentage of interest
Interest rate
Debt Instrument, Interest Rate, Stated Percentage
Retained Earnings [Member]
Accumulated Deficit
Over Allotment Option [Member]
Overallotment Option
Cristian Luput [Member]
Cristian Luput
Cristian Luput.
Document Transition Report
Document Transition Report
Percentage of stock compensation expense recognized
Percentage of Stock Compensation Expense Recognized
Percentage of stock compensation expense recognized.
Impact of the war in ukraine and war in israel on our operations.
Impact Of The War In Ukraine And War In Israel On Our OperationsPolicy [Policy Text Block]
Impact of the War in Ukraine and War in Israel on Our Operations
Laidlaw & Company Ltd
Laidlaw And Company Ltd [Member]
Laidlaw and company ltd.
Increase Decrease In Other Operating Assets
Increase (Decrease) in Other Operating Assets, Total
Other assets
Valuation Approach and Technique [Domain]
Antidilutive Security, Excluded EPS Calculation [Table]
Derivative Liability, Statement of Financial Position [Extensible Enumeration]
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
Weighted average Exercise Price, Exercised
Accrued compensation
Deferred compensation
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation
Class of warrants weighted average exercise price.
Class Of Warrants Weighted Average Exercise Price
Weighted Average Exercise Price, Ending balance
Weighted Average Exercise Price, Beginning balance
Auditor Firm ID
Minimum [Member]
Minimum
Common Stock [Member]
Common Stock
MAIA Common Stock
Accrued Expenses
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Additional Paid In Capital [Member]
Additional Paid-In Capital
Entity Well-known Seasoned Issuer
Foreign Currency Transactions And Translations Policy [Text Block]
Foreign Currency Translation
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]
Adjustments to reconcile net loss to net cash used in operating activities:
Pension Plan
Pension Plan [Member]
Statement of Income Location, Balance [Domain]
Income Statement Location
Son Of Company Director Stan Smith [Member]
Son of company director stan smith.
Son of Company Director Stan Smith
Term of agreement.
Term Of Agreement
Term of agreement
Other Assets Noncurrent
Other assets
Stockholder purchased
Percentage of Stockholder Purchased
Percentage of stockholder purchased
Warrants issued to underwriters in connection with the follow-on offering
Warrants issued to underwriters in connection with the follow-on offering.
Warrants Issued To Underwriters In Connection With The Follow-on Offering
Entity Common Stock, Shares Outstanding
Entity Common Stock Shares Outstanding
Basis of Accounting, Policy [Policy Text Block]
Basis of Presentation
Warrants issued to underwriters in connection with the direct offering.
Warrants Issued To Underwriters In Connection With The Direct Offering
Warrants issued to underwriters in connection with the direct offering
Title and Position [Domain]
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
Issuance of common shares in connection with intial public offering, issuance cost
Balance, end of period
Balance, beginning of period
Warrant liability
Warrants and Rights Outstanding
Warrants
U.S. loss
Income (Loss) from Continuing Operations before Income Taxes, Domestic
Common Stock Value
Common stock, $0.0001 par value, 70,000,000 shares authorized at December 31, 2024 and December 31, 2023, 26,157,788 and 16,986,254 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively
Percentage of probability of equity financing maturity
Percentage Of Probability Of Equity Financing Maturity
Percentage of probability of equity financing maturity.
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Investment Income, Interest
Interest income
Private Placement One [Member]
Private placement 1
Private Placement One
Aggregate offering price under sales agreement.
Aggregate Offering Price under Sales Agreement
Aggregate offering price
Schedule of warrant exercised.
Schedule Of Warrant Exercised Table [Text Block]
Schedule of Warrant Exercised
Effective Income Tax Rate Reconciliation Warrant Amendments
Effective income tax rate reconciliation warrant amendments.
Warrant amendments
Follow On Offering.
Follow On Offering [Member]
Follow-on Offering
Increase Decrease in Research and Development Incentives Receivable
Increase decrease in research and development incentives receivable.
Australia research and development incentives receivable
Measurement Frequency [Axis]
Schedule Of Accrued Liabilities Table [Text Block]
Schedule of Accrued Expenses
Net operating loss carryforwards
Deferred Tax Assets, Operating Loss Carryforwards
Deferred Tax Assets, Operating Loss Carryforwards, Total
Commitments And Contingencies
Commitments and contingencies (Note 7)
Percentage Of Stock Owned
Percentage of stock owned.
Stock owned
Share-Based Payment Arrangement, Plan Modification, Incremental Cost
Additional incremental stock compensation
Weighted Average Number Of Diluted Shares Outstanding
Weighted average common shares outstanding diluted
Weighted Average Number of Shares Outstanding, Diluted, Total
Going Concern Considerations
Going Concern Considerations [Policy Text Block]
Going concern considerations.
Percentage of royalty payments on net sales.
Percentage Of Royalty Payments On Net Sales
Rate of royalties on net sales
At-the-Market Equity Offering
At-the-market equity offering.
At-the-Market Equity Offering [Member]
At-The-Market Financing
Cybersecurity Risk Management Third Party Engaged [Flag]
Proceeds from direct offering.
Proceeds From Direct Offering
Proceeds from direct offering
Concentration Risk Benchmark [Domain]
Entity Small Business
Entity Small Business
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
2018 Stock Option Plan
Two thousand eighteen stock option plan.
Two Thousand Eighteen Stock Option Plan [Member]
Convertible Notes Payable
Debt Disclosure [Text Block]
Private Placement Round 2
Private Placement Offering Two [Member]
Private placement offering two.
Revenues
Net sales
Revenues, Total
Increase common stock capital shares reserved for future issuance
Increase common stock capital shares reserved for future issuance
Increase Common Stock, Capital Shares Reserved for Future Issuance
Private Placement Offering Three [Member]
Private placement offering three.
Private Placement Round 3
Stockholders' Equity Note, Stock Split, Conversion Ratio
Common stock, conversion ratio
Balance, beginning of period
Balance, end of period
Derivative liability, bifurcated put contained in convertible notes payable
Derivative Liability
Derivative Liability, Total
Unrelated Third Parties
Unrelated Third Parties [Member]
Unrelated third parties.
2020 warrants
Two Thousand And Twenty Warrants [Member]
Two Thousand And Twenty Warrants [Member]
Derivative liabilities:
Derivative Liability [Abstract]
General and administrative expenses and research and development expenses.
General And Administrative Expenses And Research And Development Expenses [Member]
Compensation Related Costs Policy [Text Block]
Stock-Based Compensation
Shares vesting commencement date
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Vesting Commencement Date
Share-based compensation arrangement by share-based payment award, shares vesting commencement date
Net Cash Provided By Used In Financing Activities [Abstract]
Cash flows from financing activities:
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
Weighted Average Exercise Price, Ending balance
Weighted Average Exercise Price, Beginning balance
Class Of Warrants Vested
Class of warrants vested.
Warrants vested shares
Amortization Of Debt Discount Premium
Amortization of debt discount
Shares vesting over period
Share-Based Compensation Arrangement by Share-Based Payment Award, Vesting Over Period, Number
Share-based compensation arrangement by share-based payment award, vesting over period, number
2020 Promissory Note
Two Thousand And Twenty Promissory Note [Member]
Two Thousand And Twenty Promissory Note [Member]
Issuance of stock options to settle accrued bonus balance
Issuance of Stock Options to Settle Accrued Bonus Balance
Issuance of stock options to settle accrued bonus balance.
State
State and Local Jurisdiction [Member]
Measurement Frequency [Domain]
Amended and restated two thousand twenty equity incentive plan.
Amended And Restated Two Thousand Twenty Equity Incentive Plan [Member]
Amended and Restated 2020 Equity Incentive Plan
Valuation allowance
Deferred Tax Assets, Valuation Allowance
Level 3
Fair Value, Inputs, Level 3 [Member]
Subsequent Events [Text Block]
Subsequent Events
Working capital.
Working Capital
Working capital
Previously paid issuance costs in connection with the initial public offering
Previously paid issuance costs in connection with the initial public offering
Consulting expense for restricted shares issued.
Consulting Expense For Restricted Shares Issued
Consulting expense for restricted shares issued
Cybersecurity Risk Management Positions or Committees Responsible [Flag]
Accounts Payable Current
Accounts payable
Accounts Payable, Current, Total
Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]
Total liabilities
Liabilities, Fair Value Disclosure
Percentage of conversion price
Percentage Of Conversion Price
Percentage of conversion price.
Private Placement Offering April 2024 [Member]
Private placement offering april 2024
Private Placement Offering April 2024
Private Placement Offering One [Member]
Private placement offering one.
Private Placement Offering 1
Private Placement Round 1
Increase Decrease In Accrued Liabilities
Accrued expenses
Increase (Decrease) in Accrued Liabilities, Total